e-learning
resources
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevention of COPD exacerbations: medications and other controversies
Vestbo Jørgen, Lange Peter
Source:
ERJ Open Res 2015; 1: 00011-2015
Journal Issue:
May
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Vestbo Jørgen, Lange Peter. Prevention of COPD exacerbations: medications and other controversies. ERJ Open Res 2015; 1: 00011-2015
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Prevention and management of COPD exacerbations
Source: International Congress 2016 – China Session II
Year: 2016
Prevention and treatment of COPD exacerbations
Source: International Congress 2018 – PG9 Chronic obstructive pulmonary disease exacerbations
Year: 2018
Prevention of COPD exacerbations
Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview
Year: 2012
Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010
Causes and management of exacerbations of COPD
Source: ISSN=ISSN 1810-6838, ISBN=, page=250
Year: 2007
Prevention and management of exacerbations of asthma and COPD
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010
Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Impact of mucolytic treatment on COPD exacerbations
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
COPD exacerbations: Causes and consequences
Source: ERS Live 2007
Year: 2007
Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014
Antibiotics in COPD exacerbations: practice and evidence
Source: Breathe 2009; 5: 299-301
Year: 2009
LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Role of comorbidities on mortality in patients hospitalized for COPD exacerbations
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept